Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?Friday, August 9, 2024Availability, Epidemiological impactRead More
Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.Friday, August 9, 2024Availability, Epidemiological impactRead More
An effective vaccine is only the first step: the need to create and sustain demand for TB vaccinesFriday, August 9, 2024Acceptability, Acceptability and demand, Implementation strategies and feasibilityRead More
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Implementation strategies and feasibilityRead More
Potential impact of tuberculosis vaccines in China, South Africa, and IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Impact of targeted tuberculosis vaccination among a mining population in South Africa: A model based studyFriday, August 9, 2024Availability, Epidemiological impactRead More
Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and ChinaFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsideredFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More